Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with pulmonary infections

L. N. Bisenkov, A. V. Salamatov, O. V. Barinov, T. N. Suborova, I. V. Deinega, O. G. Mar‘eva (St. Petersburg, Russian Federation)

Source: Annual Congress 2006 - Infection, trauma and emphysema
Session: Infection, trauma and emphysema
Session type: Thematic Poster Session
Number: 1587
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. N. Bisenkov, A. V. Salamatov, O. V. Barinov, T. N. Suborova, I. V. Deinega, O. G. Mar‘eva (St. Petersburg, Russian Federation). Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with pulmonary infections. Eur Respir J 2006; 28: Suppl. 50, 1587

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Continuous epidural ropivacaine infusion reduces intra-abdominal pressure, postoperative pain and normalizes lungs' mechanical changes in critically ill children after major abdominal operation
Source: Annual Congress 2013 –Clinical applications of respiratory physiology in children
Year: 2013

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP
Source: Eur Respir J 2013; 41: 123-130
Year: 2013



Switch from intravenous to oral antibiotic therapy in hospitalized patients with non-severe community acquired pneumonia
Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Year: 2010



Efficiency of intravenous treatment with levofloxacin in patients with MDR pulmonary tuberculosis in the intensive phase of chemotherapy
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004

Pharmacokinetics of instilled versus nebulized tobramycin or Imipenem in mechanically ventilated ICU patients
Source: Eur Respir J 2002; 20: Suppl. 38, 16s
Year: 2002

High flow nasal cannula therapy improves clinical and gas exchange parameters in children with acute bronchiolitis
Source: Annual Congress 2013 –Neonatal and paediatric intensive care
Year: 2013


The use of intravenous aminophylline in treatment of exacerbations of COPD
Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD
Year: 2004


Iloprost delivery and efficacy in critically ill patients
Source: Annual Congress 2007 - Problems in intensive care medicine
Year: 2007


Non invasive spontaneous dual ventilation in critically ill patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Noninvasive ventilation in acute respiratory failure: the recipe for success
Year: 2015


Randomised controlled trial of sequential intravenous and oral azithromycin compared with intravenous ceftriaxone followed by cefixime both in combination with clarithromycin in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Potential economic savings of administration of home intravenous antibiotic therapy to patients with acute respiratory infections in Ireland
Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care
Year: 2011


Long-term safety and outcome of subcutaneous and intravenous treprostinil in patients with severe chronic pulmonary hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019

Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012


Population pharmacokinetics and pharmacodynamics analysis of vancomycin in patients with severe lower respiratory tract gram-positive infections
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Clinical efficacy of bolus versus continuous-infusion of piperacillin-tazobactam in VAP treatment
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Effect of antibiotic prophylaxis on pneumonia in cardiac arrest patients treated with therapeutic hypothermia
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012


Initial intravenous antibiotic regimen in patients hospitalized for community acquired pneumonia (CAP) in France
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003

The use of piperacillin/tazobactam for treatment of pneumonia in neutropenic patients
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010


Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19.
Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19
Year: 2021